Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the interest coverage ratio high or low?
The interest coverage ratio of -2354.17x is 34% above its 2-year average of -3552.11x, near the high end of its 2-year range (-7750.50x–-551.65x).
As of the fiscal period ended Wednesday, December 31, 2025. 53.40% above its 12-month average of -5052.33x.
Reported quarterly interest coverage; no daily interpolation. Q4 FY2025 (2025-12-31): -2354.17x.
INTEREST COVERAGE RATIO
-2354.17x
INTEREST COVERAGE RATIO AVG TTM
-5052.33x
INTEREST COVERAGE RATIO AVG 3Y
N/A
INTEREST COVERAGE RATIO AVG 5Y
N/A
INTEREST COVERAGE RATIO AVG 10Y
N/A
INTEREST COVERAGE RATIO AVG 15Y
N/A
INTEREST COVERAGE RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+53.40%
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-6.38x
median of 528 covered companies
CURRENT VS SECTOR MEDIAN
-36828.10%
vs the sector median at left
OnKure Therapeutics, Inc.
Market Cap
$97.60M
Interest Coverage Ratio
-2354.17x
TTM Avg
-5052.33x
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$97.67M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$96.58M
Interest Coverage Ratio
2.53x
TTM Avg
4.25x
3Y Avg
3.46x
5Y Avg
3.46x
Market Cap
$94.72M
Interest Coverage Ratio
-16.28x
TTM Avg
11.76x
3Y Avg
11.76x
5Y Avg
11.76x
Market Cap
$100.71M
Interest Coverage Ratio
N/A
TTM Avg
2.91x
3Y Avg
2.91x
5Y Avg
2.91x
Market Cap
$103.43M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$104.00M
Interest Coverage Ratio
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | INTEREST COVERAGE RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| OnKure Therapeutics, Inc. (OKUR) | $97.60M | -2354.17x | -5052.33x | N/A | N/A |
| Korro Bio, Inc. (KRRO)vs › | $97.44M | N/A | N/A | N/A | N/A |
| PolyPid Ltd. (PYPD)vs › | $98.16M | -48.13x | N/A | N/A | N/A |
| Conexeu Sciences Inc. (CNXU)vs › | $97.67M | N/A | N/A | N/A | N/A |
| Park Dental Partners, Inc. Common Stock (PARK)vs › | $96.58M | 2.53x | 4.25x | 3.46x | 3.46x |
| Milestone Pharmaceuticals Inc. (MIST)vs › | $94.72M | -16.28x | 11.76x | 11.76x | 11.76x |
| The Joint Corp. (JYNT)vs › | $100.71M | N/A | 2.91x | 2.91x | 2.91x |
| Anixa Biosciences, Inc. (ANIX)vs › | $103.43M | N/A | N/A | N/A | N/A |
| Black Diamond Therapeutics, Inc. (BDTX)vs › | $104.00M | N/A | N/A | N/A | N/A |
| Biomea Fusion, Inc. (BMEA)vs › | $90.38M | N/A | N/A | N/A | N/A |
Interest Coverage
-2354.2x
Debt/Equity
0.01
Current Ratio
26.75
Formula: Interest Coverage = EBIT / Interest Expense
Reference ranges:
Note: Interest coverage should be compared with historical interest expense, operating income, and industry capital structure.
Interest Coverage = EBIT / Interest Expense
The interest coverage ratio measures operating earnings relative to interest expense.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | INTEREST COVERAGE RATIO |
|---|---|
| 2025-12-31 | -2354.17x |
| 2025-09-30 | -7750.50x |
| 2024-06-30 | -551.65x |
